Clinical Trial Update: Empagliflozin on Patients With Preserved Heart Failure [NA]

View source ↗

Summary

A clinical trial evaluating empagliflozin in patients with heart failure with preserved ejection fraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Damanhour University | Conditions: Heart Failure | NA | Status: COMPLETED